Washington, D.C. – The National Industrial Hemp Council (NIHC) wrote to the U.S. Food and Drug Administration (FDA) in response to the agency’s request for comments on Scientific Data and Information About Products Containing Cannabis or Cannabis-Derived Compounds.
NIHC encouraged the FDA to adopt sensible rules that permit the continued safe use of hemp-derived and CBD-infused products. NIHC expressed a strong belief that consumers have the right to fact-based information and to be able to safely use products. The safety and education of consumers is a paramount goal of the NIHC. The work of the FDA in this regard is critical to safety and protection of the public. Consumers should have access to the benefits of CBD and other hemp-derived products, safely.
The letter is available here: NIHC Comment